The estrogenic behavior of PhIP has been shown to increase the invasiveness of breast cancer cells (Lauber and Gooderham 2011) but the role of ER in the genotoxicity and metabolic activation of PhIP has not been explored. This evidence concerns the gene ESR1 and breast carcinoma.